Williams Industrial Services Group Provides Fiscal 2022 Guidance
ATLANTA–(BUSINESS WIRE)–Williams Industrial Services Group Inc. (NYSE American: WLMS) (“Williams” or the “Company”), a construction…
News
Lincoln Financial Network’s New Partnership Launches to Support Financial Professionals of Color and Broaden Access to Financial Advice
Lincoln Financial Network’s African American Financial Professionals Network Partners with CHIP Professionals, a Leading Digital…
D.A. Davidson Advises NinjaTrader on Its Acquisition of Tradovate
Transaction highlights D.A. Davidson’s deep expertise across the Capital Markets Technology ecosystem NEW YORK–(BUSINESS WIRE)–#DADavidsonIB—D.A….
Prices for Consumer Goods are Rising Quickest in America’s Top Migration Destinations
—Atlanta, Phoenix and Tampa have relatively high rates of inflation—between 8% and 9%—and they’re all…
Santander Holdings USA, Inc. Announces Federal Reserve Approval of its Acquisition of the Shares It Does Not Own of Santander Consumer USA Holdings Inc. and the Expiration of its Tender Offer to Acquire Such Shares
BOSTON–(BUSINESS WIRE)–Santander Holdings USA, Inc. (“SHUSA”) today announced that the Board of Governors of the…
Phillips 66 Partners Reports Fourth-Quarter 2021 Financial Results
Fourth-quarter earnings of $286 million and adjusted EBITDA of $400 million Reached agreement for Phillips…
Lava Therapeutics Announces Participation in the SVB Leerink 11th Annual Global Healthcare Conference 2022
UTRECHT, The Netherlands and PHILADELPHIA, Jan. 28, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
Phillips 66 Reports Fourth-Quarter 2021 Financial Results
Fourth Quarter Reported fourth-quarter earnings of $1.3 billion or $2.88 per share; adjusted earnings of…
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project
The Northern Lights joint venture between Equinor, Shell, and TotalEnergies will use the DELFI environment…
Okta Appoints Brett Tighe as Chief Financial Officer
SAN FRANCISCO–(BUSINESS WIRE)–Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced that Brett…
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project
The Northern Lights joint venture between Equinor, Shell, and TotalEnergies will use the DELFI environment…
Church & Dwight Reports Fourth Quarter and Full Year 2021 Results
2021 Fourth Quarter Results Net Sales growth +5.7%: Domestic +5.1%, Int’l +5.9%, SPD 12% Organic…
VF Reports Third Quarter Fiscal 2022 Results; Reaffirms Full Year Fiscal 2022 Earnings Outlook
Revenue from continuing operations increased 22 percent (up 22 percent in constant dollars) to $3.6…
NuStar Energy L.P. Declares Fourth Quarter 2021 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its Board of Directors has…
TPG RE Finance Trust, Inc. Announces CEO Appointment
Incoming CEO Doug Bouquard also named Partner of TPG NEW YORK–(BUSINESS WIRE)–TPG RE Finance Trust,…
DocGo Announces Record Preliminary Fourth Quarter 2021 Revenue
Full year and fourth quarter revenue of $305.0 million and $107.8 million, respectively, more than…
Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies
KENILWORTH, N.J. & MIAMI–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States…
Dataiku Expands UK Team With Appointment of Simone Larsson, AI Evangelist
The leading AI unicorn welcomes former Accenture and Digital Catapult senior AI strategist to its…
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the US with Homology Medicines as 20% owner
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into…
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner
Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV…